X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Australia’s opportunity to lead the TPP forward

By Jay Taylor  |    September 18, 2015
New Australian Prime Minister Malcolm Turnbull is certainly going to have a busy autumn. As he works to form a new government, Australia must also strive to complete negotiations in the...   Read More

Free Trade Agreements May Be Good For Your Health

By Mark Grayson  |    August 27, 2015
A new report by the Geneva Network titled “Trading for Health: Quantifying the Impact of Free Trade Agreements on Health Outcomes” recently called into question many claims being made by groups...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    August 14, 2015
Fact Check Friday: The myth about there being no negotiation in Medicare Part D looms large. In this week’s Fact Check Friday, we debunk this myth and delve into how large, powerful purchasers...   Read More

ICYMI: Wall Street Journal and Washington Post Say TPP Should Protect Medical Innovation

By Tina Stow  |    August 11, 2015
In case you missed it, The Wall Street Journal and The Washington Post editorialized yesterday on the Trans-Pacific Partnership (TPP) and the importance of reaching a trade deal that protects U.S....   Read More

Medicine Spending Relatively Stable Following Increased Regulatory Data Protection in Canada and Japan

By Mark Grayson  |    July 16, 2015
There has been much discussion about the effects of adding 12 years of data protection for biologics in the TPP.  However, fears that this could add to the cost of healthcare seem to be unfounded.   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    June 19, 2015
Burden on Patients: Access to medicines is important for patients who are managing chronic conditions. In the latest edition of the ”Burden on Patients” series, we’re taking a look at the barriers...   Read More

3 Reasons Innovation Depends On Strong IP Protections in the TPP

By Tina Stow  |    June 16, 2015
As Congress continues to debate Trade Promotion Authority (TPA), it is important to keep in mind why the Trans-Pacific Partnership (TPP) – the largest trade deal in history – can and should help...   Read More

Witnessing a Historic Moment in U.S.-Japan Relations

By Guest Contributor  |    April 30, 2015
Masao Yoshida is the President and CEO of Astellas US LLC.Prime Minister Shinzo Abe addressed a Joint Session of Congress on Wednesday, April 29, 2015 at the U.S. Capitol.  It was a historic...   Read More

Prime Minister Abe’s Visit is an Important Step Toward Strengthening Innovation

By Jay Taylor  |    April 29, 2015
Today was an historic day for Japanese Prime Minister Shinzo Abe, who arrived in the U.S. on Sunday for a week-long visit and became the first Japanese leader to address a joint session of...   Read More

U.S. Trade Representative Continues the Vital IP Dialogue

By Jay Taylor  |    February 24, 2015
Understanding how intrinsic intellectual property (IP) is to the United States economy (innovative industries support more than a quarter of all jobs in the U.S.), the Office of the U.S. Trade...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates